Associations of genetic polymorphisms of Siglecs with human diseases

Glycobiology

Volumn 24, Issue 9, 2014, Pages 785-793

  Angata, Takashi ^a  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

association study; disease; polymorphism; Siglec

Indexed keywords

ALLOANTIBODY; CD22 ANTIGEN; CD33 ANTIGEN; MYELIN ASSOCIATED GLYCOPROTEIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; SIGLEC 8; SIGLEC XII; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ASTHMA; AUTOIMMUNE DISEASE; B CELL LEUKEMIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASES; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFANT DISEASE; NEUROLOGIC DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; ANIMAL; GENETICS; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ALZHEIMER DISEASE; ANIMALS; ASTHMA; AUTOIMMUNE DISEASES; HUMANS; LEUKEMIA, B-CELL; POLYMORPHISM, SINGLE NUCLEOTIDE; SIALIC ACID BINDING IMMUNOGLOBULIN-LIKE LECTINS;

EID: 84905507434     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu043     Document Type: Review

References (103)

1. Ali SR, Fong J, Carlin AF, Busch TD, Linden R, Angata T, Areschoug T, Parast M, Varki N, Murray J, et al. 2014. Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to Group B Streptococcus. J Exp Med. 211:1231-1242.
2. Angata T, Hingorani R, Varki NM, Varki A. 2001. Cloning and characterization of a novel mouse Siglec, mSiglec-F: Differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters. J BiolChem. 276:45128-45136.
3. Angata T, Ishii T, Motegi T, Oka R, Taylor RE, Soto PC, Chang YC, Secundino I, Gao CX, Ohtsubo K, et al. 2013. Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation. Cell Mol Life Sci. 70:3199-3210.
4. Angata T, Kerr SC, Greaves DR, Varki NM, Crocker PR, Varki A. 2002. Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by issue macrophages, including brain microglia. J BiolChem. 277:24466-24474.
5. Angata T, Margulies EH, Green ED, Varki A. 2004. Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms. Proc Natl Acad Sci USA. 101: 13251-13256.
6. Angata T, Varki NM, Varki A. 2001. A second uniquely human mutation affecting sialic acid biology. J Biol Chem. 276:40282-40287.
7. Ariga T, McDonald MP, Yu RK. 2008. Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease-a review. J Lipid Res. 49:1157-1175.
8. Blixt O, Collins BE, Van Den Nieuwenhof IM, Crocker PR, Paulson JC. 2003. Sialoside specificity of the Siglec family assessed using novel multivalent probes: Identification of potent inhibitors of myelin associated glycoprotein. J Biol Chem. 278:31007-31019.
9. Boccuto L, Aoki K, Flanagan-Steet H, Chen CF, Fan X, Bartel F, Petukh M, Pittman A, Saul R, Chaubey A, et al. 2014. A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. Hum Mol Genet. 23:418-433.
10. Bochner BS. 2009. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors. Clin Exp Allergy. 39:317-324.
11. Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, Rosenkrantz LL, Imboywa S, Lee M, Von Korff A, et al. 2013. CD33 Alzheimer's disease locus: Altered monocyte function and amyloid biology. Nat Neurosci. 16:848-850.
12. Brinkman-Van der Linden EC, Angata T, Reynolds SA, Powell LD, Hedrick SM, Varki A. 2003. CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice. Mol Cell Biol. 23: 4199-4206.
13. Brinkman-Van der Linden EC, Varki A. 2000. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. J Biol Chem. 275:8625-8632.
14. Cao H, Lakner U, de Bono B, Traherne JA, Trowsdale J, Barrow AD. 2008. SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans. Eur J Immunol. 38:2303-2315.
15. Cariappa A, Takematsu H, Liu H, Diaz S, Haider K, Boboila C, Kalloo G, Connole M, Shi HN, Varki N, et al. 2009. B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase. J Exp Med. 206:125-138.
16. Carlin AF, Chang YC, Areschoug T, Lindahl G, Hurtado-Ziola N, King CC, Varki A, Nizet V. 2009. Group B treptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. J Exp Med. 206:1691-1699.
17. Chellappa V, Taylor KN, Pedrick K, Donado C, Netravali IA, Haider K, Cariappa A, Dalomba NF, Pillai S. 2013. M89V sialic acid acetyl esterase (SIAE) and all other non-synonymous common variants of this gene are atalytically normal. PLoS ONE. 8:e53453.
18. Collins BE, Kiso M, Hasegawa A, Tropak MB, Roder JC, Crocker PR, Schnaar RL. 1997. Binding specificities of the sialoadhesin family of I-type lectins-Sialic acid linkage and substructure requirements for binding of myelinassociated glycoprotein, Schwann cell myelin protein, and sialoadhesin. J Biol Chem. 272:16889-16895.
19. Collins BE, Yang LJS, Mukhopadhyay G, Filbin MT, Kiso M, Hasegawa A, Schnaar RL. 1997. Sialic acid specificity of myelin-associated glycoprotein binding. J Biol Chem. 272:1248-1255.
20. Crocker PR, Clark EA, Filbin M, Gordon S, Jones Y, Kehrl JH, Kelm S, Le Douarin N, Powell L, Roder J, et al. 1998. Siglecs: A family of sialic-acid binding lectins [letter]. Glycobiology. 8:5.
21. Crocker PR, Paulson JC, Varki A. 2007. Siglecs and their roles in the immune system. Nat Rev Immunol. 7:255-266.
22. Cyster JG, Goodnow CC. 1997. Tuning antigen receptor signaling by CD22: Integrating cues from antigens and the microenvironment. Immunity. 6:509-517.
23. Dawidowicz K, Dieude P, Avouac J, Wipff J, Hachulla E, Diot E, Tiev K, Cracowski JL, Mouthon L, Amoura Z, et al. 2011. Association study of B-cell marker gene polymorphisms in European Caucasian patients with systemic sclerosis. Clin Exp Rheumatol. 29:839-842.
24. Deng YL, Liu LH,Wang Y, Tang HD, Ren RJ, XuW, Ma JF,Wang LL, Zhuang JP, Wang G, et al. 2012. The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer's disease. Hum Genet. 131:1245-1249.
25. Edvardson S, Baumann AM, Muhlenhoff M, Stephan O, Kuss AW, Shaag A, He L, Zenvirt S, Tanzi R, Gerardy-Schahn R, et al. 2013. West syndrome caused by ST3Gal-III deficiency. Epilepsia. 54:e24-e27.
26. Evans DM, Purcell S. 2012. Power calculations in genetic studies. Cold Spring Harb Protoc. 2012:664-674.
27. Floyd H, Ni J, Cornish AL, Zeng Z, Liu D, Carter KC, Steel J, Crocker PR. 2000. Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily. J Biol Chem. 275:861-866.
28. Fragaki K, Ait-El-Mkadem S, Chaussenot A, Gire C, Mengual R, Bonesso L, Beneteau M, Ricci JE, Desquiret-Dumas V, Procaccio V, et al. 2013. Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency. Eur J Hum Genet. 21:528-534
29. Freeman SD, Kelm S, Barber EK, Crocker PR. 1995. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood. 85:2005-2012.
30. Gao PS, Shimizu K, Grant AV, Rafaels N, Zhou LF, Hudson SA, Konno S, Zimmermann N, Araujo MI, Ponte EV, et al. 2010. Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) gene are associated with susceptibility to asthma. Eur J Hum Genet. 18:713-719.
31. Gibbs RA, Rogers J, Katze MG, Bumgarner R, Weinstock GM, Mardis ER, Remington KA, Strausberg RL, Venter JC, Wilson RK, et al. 2007. Evolutionary and biomedical insights from the rhesus macaque genome. Science. 316:222-234.
32. Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, Hooli B, Choi SH, Hyman BT, Tanzi RE. 2013. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 78:631-643.
33. Guo JP, Brummet ME, Myers AC, Na HJ, Rowland E, Schnaar RL, Zheng T, Zhu Z, Bochner BS. 2011. Characterization of expression of glycan ligands or Siglec-F in normal mouse lungs. Am J Respir Cell Mol Biol. 44: 238-243.
34. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA. 98:4746-4751.
35. Harduin-Lepers A, Petit D, Mollicone R, Delannoy P, Petit JM, Oriol R. 2008. Evolutionary history of the alpha2,8-sialyltransferase (ST8Sia) gene family: Tandem duplications in early deuterostomes explain most of the diversity found in the vertebrate ST8Sia genes. BMC Evol Biol. 8:258.
36. Hitomi Y, Tsuchiya N, Hasegawa M, Fujimoto M, Takehara K, Tokunaga K, Sato S. 2007. Association of CD22 gene polymorphism with susceptibility to limited cutaneous systemic sclerosis. Tissue Antigens. 69:242-249.
37. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, et al. 2011. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 43:429-435.
38. Hu H, Eggers K, Chen W, Garshasbi M, Motazacker MM, Wrogemann K, Kahrizi K, Tzschach A, Hosseini M, Bahman I, et al. 2011. ST3GAL3 mutations impair the development of higher cognitive functions. Am J Hum Genet. 89:407-414.
39. InanlooRahatloo K, Parsa AF, Huse K, Rasooli P, Davaran S, Platzer M, Kramer M, Fan JB, Turk C, Amini S, et al. 2014. Mutation in ST6GALNAC5 identified in family with coronary artery disease. Sci Rep. 4:3595.
40. Jitoku D, Hattori E, Iwayama Y, Yamada K, Toyota T, Kikuchi M, Maekawa M, Nishikawa T, Yoshikawa T. 2011. Association study of Nogo-related genes with schizophrenia in a Japanese case-control sample. Am J Med Genet B Neuropsychiatr Genet. 156B:581-592.
41. Kelm S, Pelz A, Schauer R, Filbin MT, Tang S, de Bellard ME, Schnaar RL, Mahoney JA, Hartnell A, Bradfield P, et al. 1994. Sialoadhesin, myelinassociated glycoprotein and CD22 define a new family of sialic aciddependent adhesion molecules of the immunoglobulin superfamily. Curr Biol. 4:965-972.
42. Kikly KK, Bochner BS, Freeman SD, Tan KB, Gallagher KT, D'alessio KJ, Holmes SD, Abrahamson JA, Erickson-Miller CL, Murdock PR, et al. 2000. Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. J Allergy Clin Immunol. 105:1093-1100.
43. Kiwamoto T, Brummet ME, Wu F, Motari MG, Smith DF, Schnaar RL, Zhu Z, Bochner BS. 2014. Mice deficient in the St3gal3 gene product alpha2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation. J Allergy Clin Immunol. 133:240-7.e1-3.
44. Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, Frossard P, Been LF, Chia KS, Dimas AS, Hassanali N, et al. 2011. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet. 43:984-989.
45. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, Jun G, DeStefano AL, Bis JC, Beecham GW, et al. 2013. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 45:1452-1458.
46. Lewis CM, Knight J. 2012. Introduction to genetic association studies. Cold Spring Harb Protoc. 2012:297-306.
47. Ma H, Qazi S, Ozer Z, Gaynon P, Reaman GH, Uckun FM. 2012. CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia. Br J Haematol. 156:89-98.
48. Malik M, Simpson JF, Parikh I, Wilfred BR, Fardo DW, Nelson PT, Estus S. 2013. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing. J Neurosci. 33:13320-13325.
49. Mary C, Laporte C, Parzy D, Santiago ML, Stefani F, Lajaunias F, Parkhouse RM, O'Keefe TL, Neuberger MS, Izui S, et al. 2000. Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice. J Immunol. 165:2987-2996.
50. Matsuzaki K, Kato K, Yanagisawa K. 2010. Abeta polymerization through interaction with membrane gangliosides. Biochim Biophys Acta. 1801:868-877.
51. McDonough CW, Gong Y, Padmanabhan S, Burkley B, Langaee TY, Melander O, Pepine CJ, Dominiczak AF, Cooper-Dehoff RM, Johnson JA. 2013. Pharmacogenomic association of nonsynonymous SNPs in SIGLEC12, A1BG, and the selectin region and cardiovascular outcomes. Hypertension. 62:48-54.
52. Mitra N, Banda K, Altheide TK, Schaffer L, Johnson-Pais TL, Beuten J, Leach RJ, Angata T, Varki N, Varki A. 2011. SIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomas. J Biol Chem. 286:23003-23011.
53. Mortland L, Alonzo TA, Walter RB, Gerbing RB, Mitra AK, Pollard JA, Loken MR, Hirsch B, Raimondi S, Franklin J, et al. 2013. Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapy. Clin Cancer Res. 19:1620-1627.
54. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, et al. 2011. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 43:436-441.
55. Najmabadi H, Motazacker MM, Garshasbi M, Kahrizi K, Tzschach A, Chen W, Behjati F, Hadavi V, Nieh SE, Abedini SS, et al. 2007. Homozygosity mapping in consanguineous families reveals extreme heterogeneity of nonsyndromic autosomal recessive mental retardation and identifies 8 novel gene loci. Hum Genet. 121:43-48.
56. Nutku E, Aizawa H, Hudson SA, Bochner BS. 2003. Ligation of Siglec-8: A selective mechanism for induction of human eosinophil apoptosis. Blood. 101:5014-5020.
57. O'Keefe TL, Williams GT, Batista FD, Neuberger MS. 1999. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med. 189:1307-1313.
58. O'Keefe TL, Williams GT, Davies SL, Neuberger MS. 1996. Hyperresponsive B cells in CD22-deficient mice. Science. 274:798-801.
59. Omoumi A, Fok A, Greenwood T, Sadovnick AD, Feldman HH, Hsiung GY. 2014. Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population. Neurobiol Aging. 35:936.e5-936.12.
60. Padler-Karavani V, Hurtado-Ziola N, Chang YC, Sonnenburg JL, Ronaghy A, Yu H, Verhagen A, Nizet V, Chen X, Varki N, et al. 2014. Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates. FASEB J. 28:1280-1293.
61. Pan B, Fromholt SE, Hess EJ, Crawford TO, Griffin JW, Sheikh KA, Schnaar RL. 2005. Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: Neuropathology and behavioral deficits in single-and double-null mice. Exp Neurol. 195:208-217.
62. Perez-Oliva AB, Martinez-Esparza M, Vicente-Fernandez JJ, Corral-San Miguel R, Garcia-Penarrubia P, Hernandez-Caselles T. 2011. Epitope mapping, expression and post-translational modifications of two isoforms of CD33 (CD33M and CD33m) on lymphoid and myeloid human cells. Glycobiology. 21:757-770.
63. Perlis RH, Purcell S, Fagerness J, Kirby A, Petryshen TL, Fan J, Sklar P. 2008. Family-based association study of lithium-related and other candidate genes in bipolar disorder. Arch Gen Psychiatry. 65:53-61.
64. Pillai S, Netravali IA, Cariappa A, Mattoo H. 2012. Siglecs and immune regulation. Annu Rev Immunol. 30:357-392.
65. Powell LD, Sgroi D, Sjoberg ER, Stamenkovic I, Varki A. 1993. Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition. J Biol Chem. 268:7019-7027.
66. Raj T, Ryan KJ, Replogle JM, Chibnik LB, Rosenkrantz L, Tang A, Rothamel K, Stranger BE, Bennett DA, Evans DA, et al. 2014. CD33: Increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility. Hum Mol Genet. 23:2729-2736.
67. Salminen A, Kaarniranta K. 2009. Siglec receptors and hiding plaques in Alzheimer's disease. J Mol Med (Berl). 87:697-701.
68. Schachner M, Bartsch U. 2000. Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia. 29:154-165.
69. Sethi S, Murphy TF. 2008. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 359:2355-2365.
70. Sgroi D, Varki A, Braesch-Andersen S, Stamenkovic I. 1993. CD22, a B cellspecific immunoglobulin superfamily member, is a sialic acid-binding lectin. J Biol Chem. 268:7011-7018.
71. Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, Griffin JW, Schnaar RL. 1999. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci USA. 96:7532-7537.
72. Simpson MA, Cross H, Proukakis C, Priestman DA, Neville DC, Reinkensmeier G, Wang H, Wiznitzer M, Gurtz K, Verganelaki A, et al. 2004. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet. 36:1225-1229.
73. Sjoberg ER, Powell LD, Klein A, Varki A. 1994. Natural ligands of the B cell adhesion molecule CD22 beta can be masked by 9-O-acetylation of sialic acids. J Cell Biol. 126:549-562.
74. Sturgill ER, Aoki K, Lopez PH, Colacurcio D, Vajn K, Lorenzini I, Majic S, Yang WH, Heffer M, Tiemeyer M, et al. 2012. Biosynthesis of the major brain gangliosides GD1a and GT1b. Glycobiology. 22:1289-1301.
75. Sun J, Shaper NL, Itonori S, Heffer-Lauc M, Sheikh KA, Schnaar RL. 2004. Myelin-associated glycoprotein (Siglec-4) expression is progressively and selectively decreased in the brains of mice lacking complex gangliosides. Glycobiology. 14:851-857.
76. Surolia I, Pirnie SP, Chellappa V, Taylor KN, Cariappa A, Moya J, Liu H, Bell DW, Driscoll DR, Diederichs S, et al. 2010. Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature. 466:243-247.
77. Suzukawa M, Miller M, Rosenthal P, Cho JY, Doherty TA, Varki A, Broide D. 2013. Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice. J Immunol. 190:5939-5948.
78. Tateno H, Crocker PR, Paulson JC. 2005. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6′-sulfo-sialyl Lewis X as a preferred glycan ligand. Glycobiology. 15:1125-1135.
79. Taylor VC, Buckley CD, Douglas M, Cody AJ, Simmons DL, Freeman SD. 1999. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2. J Biol Chem. 274:11505-11512.
80. Tedder TF, Tuscano J, Sato S, Kehrl JH. 1997. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu Rev Immunol. 15:481-504.
81. The Chimpanzee Sequencing and Analysis Consortium. 2005. Initial sequence of the chimpanzee genome and comparison with the human genome. Nature. 437:69-87.
82. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S. 2003. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 362:798-805.
83. Uckun FM, Goodman P, Ma H, Dibirdik I, Qazi S. 2010. CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia. Proc Natl Acad Sci USA. 107:16852-16857.
84. Varki A. 2011. Since there are PAMPs and DAMPs, there must be SAMPs? Glycan "self-associated molecular patterns" dampen innate immunity, but pathogens can mimic them. Glycobiology. 21:1121-1124.
85. Varki A, Angata T. 2006. Siglecs-the major subfamily of I-type lectins. Glycobiology. 16:1R-27R.
86. Velloso LA, Eizirik DL, Cnop M. 2013. Type 2 diabetes mellitus-an autoimmune disease? Nat Rev Endocrinol. 9:750-755.
87. Voineskos AN, de Luca V, Bulgin NL, van Adrichem Q, Shaikh S, Lang DJ, Honer WG, Kennedy JL. 2008. A family-based association study of the myelin-associated glycoprotein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase genes with schizophrenia. Psychiatr Genet. 18:143-146.
88. von Gunten S, Schaub A, Vogel M, Stadler BM, Miescher S, Simon HU. 2006. Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations. Blood. 108:4255-4259.
89. von Gunten S, Vogel M, Schaub A, Stadler BM, Miescher S, Crocker PR, Simon HU. 2007. Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies. J Allergy Clin Immunol. 119:1005-1011.
90. Vyas AA, Patel HV, Fromholt SE, Heffer-Lauc M, Vyas KA, Dang J, Schachner M, Schnaar RL. 2002. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci USA. 99:8412-8417.
91. Wan C, Yang Y, Feng G, Gu N, Liu H, Zhu S, He L, Wang L. 2005. Polymorphisms of myelin-associated glycoprotein gene are associated with schizophrenia in the Chinese Han population. Neurosci Lett. 388:126-131.
92. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, et al. 2011. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 17:610-617.
93. Xu C, Aragam N, Li X, Villla EC, Wang L, Briones D, Petty L, Posada Y, Arana TB, Cruz G, et al. 2013. BCL9 and C9orf5 are associated with negative symptoms in schizophrenia: Meta-analysis of two genome-wide association studies. PLoS ONE. 8:e51674.
94. Yamanaka M, Kato Y, Angata T, Narimatsu H. 2009. Deletion polymorphism of SIGLEC14 and its functional implications. Glycobiology. 19:841-846.
95. Yanagisawa K. 2007. Role of gangliosides in Alzheimer's disease. Biochim Biophys Acta. 1768:1943-1951.
96. Yang YF, Qin W, Shugart YY, He G, Liu XM, Zhou J, Zhao XZ, Chen Q, La YJ, Xu YF, et al. 2005. Possible association of the MAG locus with schizophrenia in a Chinese Han cohort of family trios. Schizophr Res. 75:11-19.
97. Yasui K, Angata T, Matsuyama N, Furuta RA, Kimura T, Okazaki H, Tani Y, Nakano S, Narimatsu H, Hirayama F. 2011. Detection of anti-Siglec-14 alloantibodies in blood components implicated in nonhaemolytic transfusion reactions. Br J Haematol. 153(6):794-796.
98. Yngvadottir B, Xue Y, Searle S, Hunt S, Delgado M, Morrison J, Whittaker P, Deloukas P, Tyler-Smith C. 2009. A genome-wide survey of the prevalence and evolutionary forces acting on human nonsense SNPs. Am J Hum Genet. 84:224-234.
99. Yu Z, Lai CM, Maoui M, Banville D, Shen SH. 2001. Identification and characterization of S2 V, a novel putative siglec that contains two V set Ig-like domains and recruits protein-tyrosine phosphatases SHPs. J Biol Chem. 276:23816-23824.
100. Zandi PP, Zollner S, Avramopoulos D,Willour VL, Chen Y, Qin ZS, Burmeister M, Miao K, Gopalakrishnan S, McEachin R, et al. 2008. Family-based SNP association study on 8q24 in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 147B:612-618.
101. Zhang JQ, Biedermann B, Nitschke L, Crocker PR. 2004. The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils. Eur J Immunol. 34:1175-1184.
102. Zhang M, Angata T, Cho JY, Miller M, Broide DH, Varki A. 2007. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Blood. 109:4280-4287.
103. Zhang P, Xiang N, Chen Y, Sliwerska E, McInnis MG, Burmeister M, Zollner S. 2010. Family-based association analysis to finemap bipolar linkage peak on chromosome 8q24 using 2,500 genotyped SNPs and 15,000 imputed SNPs. Bipolar Disord. 12:786-792.